Moreover, medications targeting the S protein have only one chance to fight the coronaviral-2 infection, since after passage of any viral particles inside the host body (or if these therapies were taken after the occurrence of the infection) there will not be any further abilities of these therapies to stop virus propagation and infection. Here, PROS1 is linked to infection.